<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="0e382487-a6ee-4d29-90f8-4467d6cbdff3"><labelDrug name="PrismaSol BGK0/2.5"><Normalization/></labelDrug><generic name="Calcium Chloride, Magnesium Chloride, Anhydrous Dextrose, Lactic Acid, Sodium Chloride, and Sodium Bicarbonate"/><sentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.2" text="PrismaSol solution is indicated in adults and children for use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolytes and acid-base imbalances." type="negative"><entity charOffset="203:215" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.2.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="and to correct electrolytes" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.2.e.1" text="prismasol" type="Biomedical_Entity"><Normalization><mmtx cui="C2978157" phraseText="PrismaSol solution" preferredWord="PRISMASOL" semType="phsu, orch"/><RxNorm RxCui="1088314"/></Normalization></entity><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.2.e.1" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.2.e.0"/></sentence><sentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.5" text="The mode of therapy, solute formulation, flow rates and length of therapy should be selected by the physician responsible for managing treatment depending on the clinical condition of the patient as well as the patient's fluid, electrolyte, acid base and glucose balance. " type="negative"><entity charOffset="255:262" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.5.e.0" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="glucose balance." preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="228:239" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.5.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="electrolyte," preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.5.e.1" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.5.e.0"/></sentence><sentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.12" text="The electrolyte solution contained in compartment A must be mixed with the buffer solution of compartment B before use in order to obtain the reconstituted solution suitable for hemofiltration /hemodiafiltration." type="negative"><entity charOffset="75:81" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.12.e.0" text="buffer" type="Biomedical_Entity"><Normalization><mmtx cui="C0006353" phraseText="mixed with the buffer solution of compartment B" preferredWord="Buffers" semType="phsu, irda"/><RxNorm RxCui="604979"/></Normalization></entity><entity charOffset="4:24" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.12.e.1" text="electrolyte solution" type="Biomedical_Entity"><Normalization><mmtx cui="C0308944" phraseText="The electrolyte solution" preferredWord="Oral electrolyte solution" semType="clnd"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.12.e.1" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.12.e.0"/></sentence><sentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19" text="Note that citrate, when used as an anticoagulant, contributes to the base load and can reduce plasma calcium levels." type="negative"><entity charOffset="101:108" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="plasma calcium levels." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="10:17" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.1" text="citrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0376259" phraseText="that citrate," preferredWord="Citrate" semType="phsu, orch"/><RxNorm RxCui="114200"/></Normalization></entity><entity charOffset="35:48" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.2" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="used as an anticoagulant," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.1" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.0"/><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.2" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.0"/><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.1" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.19.e.2"/></sentence><sentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20" text="During hemofiltration or hemodiafiltration, abnormalities in the plasma concentration of potassium, calcium, and glucose may develop. " type="negative"><entity charOffset="113:120" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.0" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="glucose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="100:107" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="calcium," preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="89:98" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="abnormalities in the plasma concentration of potassium," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.1" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.0"/><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.2" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.0"/><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.2" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.20.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31" lineNumber="41" text="Patients may require initiation of insulin therapy or modification of insulin dosage during treatment with PrismaSol solution. " type="regular"><entity charOffset="107:125" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.0" text="PrismaSol solution" type="Drug"><Normalization><mmtx cui="C2978157" phraseText="with PrismaSol solution." preferredWord="PRISMASOL" semType="phsu, orch"/><RxNorm RxCui="1088314"/></Normalization></entity><entity charOffset="54:69|78:84" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.1" text="modification of dosage" type="Caution_Interaction"/><entity charOffset="70:77" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.3" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="modification of insulin dosage" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="modification of insulin dosage" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="modification of insulin dosage" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><drugInteraction id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.ddi.1"><interaction trigger="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.3" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.0" trigger="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.32" text="Appropriate monitoring of blood glucose should be performed and insulin dosage adjusted accordingly." type="negative"><entity charOffset="32:39" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.32.e.0" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="Appropriate monitoring of blood glucose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="64:71" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.32.e.1" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C1579433" phraseText="insulin dosage" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><pair ddi="false" e1="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.32.e.0" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.32.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36" lineNumber="47" text="In patients with cardiovascular disease, especially those using cardiac glycoside medications, plasma levels of calcium, potassium and magnesium must be carefully monitored." type="irregular"><entity charOffset="17:39" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.e.0" text="cardiovascular disease" type="SPAN"><Normalization><mmtx cui="C0007222" phraseText="with cardiovascular disease," preferredWord="Cardiovascular Diseases" semType="dsyn"/></Normalization></entity><entity charOffset="64:93" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.e.1" text="cardiac glycoside medications" type="Drug_Class"><Normalization><mmtx cui="C0007158" phraseText="cardiac glycoside medications," preferredWord="Cardiac Glycosides" semType="phsu, carb"/><mmtx cui="C0013227" phraseText="cardiac glycoside medications," preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536854" phraseText="cardiac glycoside medications," preferredWord="Cardiac Glycoside [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="cardiac glycoside medications," preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="1025351"/></Normalization></entity><entity charOffset="163:172" id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.e.2" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.ddi.1"><interaction trigger="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.e.2"><relations><relation type="hasContext"><entity id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31" text="Patients may require initiation of insulin therapy or modification of insulin dosage during treatment with PrismaSol solution. "><entity id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.31.e.0"/></ellipsisSentence><middleSentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.32" text="Appropriate monitoring of blood glucose should be performed and insulin dosage adjusted accordingly."/><middleSentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.33" text="7 DRUG INTERACTIONS"/><middleSentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.34" text="As with the use of other replacement solutions, blood concentrations of filterable drugs may be influenced by CRRT."/><middleSentence id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.35" text="The blood concentrations of certain drugs may need to be monitored and appropriate therapy implemented to correct for removal during treatment. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0e382487-a6ee-4d29-90f8-4467d6cbdff3.s.36.e.1"/></sentence><positiveExamples number="2"/><negativeExamples number="10"/></document>